Stocks in Action USA and International: Estée Lauder, Marriott, IDEXX Labs.
Reading Time: 3 minutes
IDEXX Laboratories increases revenue by 10% and raises annual forecast – strong diagnostic demand drives profit growth! IDEXX Laboratories significantly increased its revenue and profit in the third quarter of 2026, surpassing analyst expectations. Revenue rose by 10% to $1.214 billion. The comparable diluted earnings per share increased by 22% to $3.96; the adjusted consensus of $3.71 was also clearly exceeded. Operating income rose by 13% to $402.3 million, and the operating margin improved by one percentage point to 33.1%. The main growth...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.

